Zogenix

Summary

History

Mission

Vision

References

Summary

Zogenix, Inc. is a multinational biopharmaceutical company.

History

Zogenix was founded in 2005 by Scott Reznik and Stephen Farr. The company develops and commercializes pharmaceutical products for the treatment of central nervous system disorders and pain. Zogenix went public in 2010, and today has a market cap of over 3.5 billion.

Mission

At Zogenix, our mission is to develop and commercialize transformative therapeutics, bringing relief to those living with debilitating diseases while helping build healthy communities.

Vision

Zogenix’s vision is to be a global leader in developing and commercializing innovative and personalized treatments that improve the lives of patients.

References

https://in.investing.com/equities/zogenix

https://www.crunchbase.com/organization/zogenix

www.zogenix.com

Leadership team

Jonathan M. Rigby (Founder)

Roger Hawley (Founder)

Products / Services

Biotechnology, Health Care, Pharmaceutical

Number of Employees

100 - 500

Address